Kitay M K, Rowe D T
Department of Infectious Diseases and Microbiology, Graduate School of Public Health, University of Pittsburgh, Pennsylvania 15261, USA.
J Virol. 1996 Nov;70(11):7885-93. doi: 10.1128/JVI.70.11.7885-7893.1996.
EBNA-LP is a viral nuclear oncoprotein implicated in the immortalization of B lymphocytes by Epstein-Barr virus. An analysis of EBNA-LP migration on polyacrylamide gels was performed with protein derived from the X50-7 lymphoblastoid cell line blocked by hydroxyurea or aphidicolin at the G1/S phase of the cell cycle or by nocodazole at the G2/M phase. More slowly migrating species of EBNA-LP were detected in G2/M phase-arrested cell extracts. Release from nocodazole G2/M block or treatment with phosphatase caused the more slowly migrating species of EBNA-LP to disappear. Analyses of 32PO(4)(3-)-labeled EBNA-LP protein immunoprecipitated from the drug-synchronized cells showed that phosphorylated EBNA-LP was present throughout the cell cycle but that phosphorylation increased in G2 and was maximal at G2/M. Phosphoamino acid analysis revealed that all phosphorylation was on serine residues only. The ability of EBNA-LP to be phosphorylated by p34(cdc2) kinase and casein kinase II exclusively on serines implicates these enzymes as being potentially involved in EBNA-LP phosphorylation.
EBNA-LP是一种病毒核癌蛋白,与爱泼斯坦-巴尔病毒使B淋巴细胞永生化有关。利用来自X50-7淋巴母细胞系的蛋白质,对EBNA-LP在聚丙烯酰胺凝胶上的迁移进行了分析,这些蛋白质是用羟基脲或阿非迪霉素在细胞周期的G1/S期阻断细胞,或用诺考达唑在G2/M期阻断细胞后获得的。在G2/M期阻滞的细胞提取物中检测到迁移较慢的EBNA-LP种类。从诺考达唑G2/M阻滞中释放或用磷酸酶处理会导致迁移较慢的EBNA-LP种类消失。对从药物同步化细胞中免疫沉淀的32PO(4)(3-)-标记的EBNA-LP蛋白的分析表明,磷酸化的EBNA-LP在整个细胞周期中都存在,但磷酸化在G2期增加,并在G2/M期达到最大值。磷酸氨基酸分析显示,所有磷酸化仅发生在丝氨酸残基上。EBNA-LP仅在丝氨酸上被p34(cdc2)激酶和酪蛋白激酶II磷酸化的能力表明这些酶可能参与了EBNA-LP的磷酸化。